Why CABR Stock surged +5.61% Today — RQD Quant Desk Flash

Per the Roarable RQD rating, CABR scores 37 out of 100 with a letter grade of D- and a verdict label of "Roarable Sell — Vulnerable Balance Sheet & Flow." Across the five pillars: the Fundamental Cash Engine scores 9/20 (ROIC -35%; FCF yield -15.11%), indicating that the business is currently not generating returns on invested capital or free cash flow relative to its market value. Whale 13F Flow scores 4/20, reflecting weak institutional accumulation and options positioning. Insider Conviction scores 3/20 based on SEC Form 4 and Congressional PTR cluster flow. Macro Regime Fit scores 7/20 with a Beta of 1.0 and a sector sensitivity noted in the rating. Forensic Balance Sheet scores 14/20 (Altman Z 16.94; Piotroski F 4/9; Debt/Equity 0.03), the strongest pillar, indicating that the balance sheet is comparatively low in leverage even though operating performance is weak. For a prospective investor, the rating's implication is that the most favorable element is the low debt load, while the upside drivers that would normally support a stock — cash generation, institutional demand, and insider confidence — are the weakest areas in the source data. Valuation tradeoffs cannot be assessed on earnings multiples because P/E and EV/EBITDA are not available in source data, so the investment case rests on the balance sheet and flow signals rather than on earnings.

Per the SEC financials, reported revenue is $0.0M in both FY 2025 and FY 2024, with net losses of $-6.3M and $-1.5M respectively. Per the market data, operating margin and net margin are each -60%, and ROIC is -35%. Per the Roarable RQD rating, the Altman Z-Score is 16.94 and the Piotroski F-Score is 4/9, with Debt/Equity at 0.03. Cash rose from $0.5M to $2.2M while debt is reported at $0.1M for FY 2025, which the rating's forensic pillar reads as a low-leverage balance sheet.

Per the news wire, the headlines are: a Yahoo! Finance Canada item referencing CABR's seasonal returns chart; a Stock Titan item titled "Resales won't fund Caring Brands (CABR); cash could come from warrant exercises"; a Kalkine item referencing a "Nasdaq delisting dispute" with shares edging up pre-market; a TradingKey most-active-stocks item; a Kalkine Nasdaq compliance watch list item dated November 2, 2026; and a TradingKey U.S. stocks list. Each item is flagged YELLOW under the MARKET WIRE impact label. Key risk watch items from the wire are the Nasdaq delisting dispute and the reliance on warrant exercises as a cash source. The Butterfly supply-chain graph reports no supply chain and no proprietary signals.

Per the Butterfly Supply-Chain Graph, the supply chain is "NONE" with no butterfly links and no proprietary signals. Upstream and downstream dependencies cannot be identified from the source data. Sector correlation to Consumer Discretionary cannot be quantified beyond the stated Beta of 1.0. The second-order risk visible in the source is financing-related: the news wire suggests warrant exercises as a potential cash source, and the Nasdaq compliance items suggest listing-related pressure. A prospective investor should watch whether financing dilution and exchange-listing status change together.

• What products does Caring Brands sell, and through which channels and customers does it generate revenue, given reported revenue of $0.0M?
• What is the status and timeline of the Nasdaq delisting dispute referenced in the news wire?
• How much dilution would result from the warrant exercises the news wire cites as a cash source?
• Why does reported FY 2025 cash of $2.2M coexist with negative free cash flow of $-1.7M, and what funded the cash balance?
• What drove the change from FY 2024 to FY 2025 net loss, and what is the path to positive operating income?